EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals

Shawn H MacVane iD, Rena Moon iD, Joy David, Ning Rosenthal, Romney M Humphries iD

Clinical Infectious Diseases · 06.11.2025 · 81 (4) · 710-720

DOI: 10.1093/cid/ciaf165 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 01.04.2025. Verfasst von Shawn H MacVane und 4 weiteren Autor:innen. Beteiligte Einrichtung: Global Medical Affairs, bioMérieux, Hazelwood, Missouri, USA. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Anti-Bacterial Agents, Gram-Negative Bacteria, Bacteremia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid administration of effective antimicrobial therapy is crucial for managing bloodstream infections (BSIs), especially those caused by pathogens with difficult-to-treat resistance (DTR; ie, resistance to all first-line antimicrobials). The purpose of this study is to describe the epidemiology and time course of microbiological testing in US laboratories for gram-negative BSIs (GN-BSIs).

Methods

A retrospective observational cohort study of adults with GN-BSI between 1 January 2017 and 30 June 2023 was conducted using a large, geographically diverse, hospital-based administrative US database. Antimicrobial susceptibility testing (AST) reporting and time to results of traditional and next-generation antimicrobials (ceftazidime-avibactam, ceftolozane-tazobactam, cefiderocol, meropenem-vaborbactam, imipenem-relebactam) were evaluated according to the isolates’ resistance phenotype.

Results

A total of 110 322 GN-BSI episodes were included, of which 0.6% exhibited a DTR phenotype. Among all episodes, the average time to results for AST was 73.5 ± 26.7 hours from blood culture collection. The average time to AST results was longer for DTR (92.2 ± 27.8 hours) and carbapenem not-susceptible phenotypes (90.1 ± 28.0 hours) than for nonresistant phenotypes (72.9 ± 26.7 hours). Overall, 2.5% of GN-BSI episodes had AST reported for at least 1 next-generation antimicrobial, increasing from 0.2% in 2017 to 7.7% in 2023. Among patients with isolates showing DTR phenotypes, 30.5% had AST reported for at least 1 next-generation antimicrobial.

Conclusions

Time to AST results for next-generation antimicrobials and antibiotic-resistant organisms is prolonged in US laboratories for blood cultures with gram-negative organisms. Testing frequency and timing of AST reporting for next-generation antimicrobials likely contribute to their clinical utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gram-Negative Bacterial InfectionsAnti-Bacterial AgentsGram-Negative BacteriaBacteremiaHumansRetrospective StudiesUnited StatesMicrobial Sensitivity TestsMaleFemaleMiddle AgedAgedAdultHospitalsPhenotypeDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

antimicrobial susceptibility testingceftazidime-avibactamceftolozane-tazobactammeropenem-vaborbactamnext-generation antimicrobials

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Global Medical Affairs, bioMérieux, Hazelwood, Missouri, USA.
  • Premier Applied Sciences, Premier, Inc, Charlotte, North Carolina, USA.
  • Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Shawn H MacVane, Rena Moon, Romney M Humphries

Zitieren

APA

MacVane, S. H., Moon, R., David, J., Rosenthal, N., & Humphries, R. M. (2025). Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals. Clinical Infectious Diseases, 81(4), 710-720. https://doi.org/10.1093/cid/ciaf165

Vancouver

MacVane SH, Moon R, David J, Rosenthal N, Humphries RM. Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals. Clinical Infectious Diseases. 2025;81(4):710-720. doi:10.1093/cid/ciaf165

BibTeX
@article{MacVane2025,
  author = {MacVane, Shawn H and Moon, Rena and David, Joy and Rosenthal, Ning and Humphries, Romney M},
  title = {Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {81},
  number = {4},
  pages = {710--720},
  doi = {10.1093/cid/ciaf165}
}
Kostenlos starten →